Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AWARD A RESEARCH AND DEVELOPMENT SMALL BUSINESS TECHNOLOGY TRANSFER PROGRAM PHASE II ENHANCEMENT AWARD TO COALESENZ, INC FOR PROJECT TITLED, POINT OF CARE BLOOD COAGULOPATHY DIAGNOSIS. | COALESENZ INC | $549,959 | DEFENSE HEALTH AGENCY (DHA) | DEFENSE HEALTH AGENCY (DHA) | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jul 25, 2025 | Jul 28, 2025 | Aug 27, 2026 | ||
| COMBAT CASUALTY CARE RESEARCH PROGRAM (CCCRP) SMALL BUSINESS TECHNOLOGY TRANSFER PROGRAM (STTR) PHASE II TOPIC DHP198-001 POINT OF CARE BLOOD COAGULOPATHY DIAGNOSTICS | COALESENZ INC | $1,099,955 | DEPT OF THE ARMY | DEPT OF THE ARMY | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN91 | Sep 22, 2020 | Sep 24, 2020 | Jul 23, 2024 | ||
| MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER DHA STTR PH I PROPOSAL NO H19A-001-0023 TITLED POINT OF CARE BLOOD COAGULOPATHY DIAGNOSTICS | COALESENZ INC | $162,500 | DEPT OF THE ARMY | DEFENSE HEALTH AGENCY (DHA) | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN91 | Dec 19, 2019 | Dec 16, 2019 | Jul 26, 2020 |